Skip to navigation Skip to main content

Cobimetinib (Cotellic)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews cobimetinib (Cotellic), indicated for treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with vemurafenib.

Topics:

Drug Information Melanoma Skin Cancer Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides